189 related articles for article (PubMed ID: 10602517)
1. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3.
Yin Z; Spitz MR; Babaian RJ; Strom SS; Troncoso P; Kagan J
Oncogene; 1999 Dec; 18(52):7576-83. PubMed ID: 10602517
[TBL] [Abstract][Full Text] [Related]
2. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
[TBL] [Abstract][Full Text] [Related]
3. Identification of a I-cM region of common deletion on 13q14 associated with human prostate cancer.
Ueda T; Emi M; Suzuki H; Komiya A; Akakura K; Ichikawa T; Watanabe M; Shiraishi T; Masai M; Igarashi T; Ito H
Genes Chromosomes Cancer; 1999 Mar; 24(3):183-90. PubMed ID: 10451697
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1.
Zenklusen JC; Thompson JC; Troncoso P; Kagan J; Conti CJ
Cancer Res; 1994 Dec; 54(24):6370-3. PubMed ID: 7987830
[TBL] [Abstract][Full Text] [Related]
5. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP
Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291
[TBL] [Abstract][Full Text] [Related]
6. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
[TBL] [Abstract][Full Text] [Related]
7. Allelic loss on chromosome 13q in human prostate carcinoma.
Melamed J; Einhorn JM; Ittmann MM
Clin Cancer Res; 1997 Oct; 3(10):1867-72. PubMed ID: 9815575
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancer.
Ueda T; Komiya A; Suzuki H; Shimbo M; Sakamoto S; Imamoto T; Akakura K; Shiraishi T; Ichikawa T
Prostate; 2005 Aug; 64(3):265-71. PubMed ID: 15717310
[TBL] [Abstract][Full Text] [Related]
9. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer.
Hyytinen ER; Frierson HF; Boyd JC; Chung LW; Dong JT
Genes Chromosomes Cancer; 1999 Jun; 25(2):108-14. PubMed ID: 10337994
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M
Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830
[TBL] [Abstract][Full Text] [Related]
11. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes.
Kagan J; Stein J; Babaian RJ; Joe YS; Pisters LL; Glassman AB; von Eschenbach AC; Troncoso P
Oncogene; 1995 Nov; 11(10):2121-6. PubMed ID: 7478532
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
[TBL] [Abstract][Full Text] [Related]
13. Delineation of the frequently deleted region on chromosome arm 13q in B-cell non-Hodgkin's lymphoma.
Wada M; Okamura T; Okada M; Teramura M; Masuda M; Motoji T; Mizoguchi H
Int J Hematol; 2000 Feb; 71(2):159-66. PubMed ID: 10745626
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
Latil A; Cussenot O; Fournier G; Baron JC; Lidereau R
Clin Cancer Res; 1995 Nov; 1(11):1385-9. PubMed ID: 9815935
[TBL] [Abstract][Full Text] [Related]
15. Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer.
Gao X; Zacharek A; Grignon DJ; Sakr W; Powell IJ; Porter AT; Honn KV
Oncogene; 1995 Oct; 11(7):1241-7. PubMed ID: 7478543
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer.
Trapman J; Sleddens HF; van der Weiden MM; Dinjens WN; Konig JJ; Schroder FH; Faber PW; Bosman FT
Cancer Res; 1994 Dec; 54(23):6061-4. PubMed ID: 7954446
[TBL] [Abstract][Full Text] [Related]
17. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
18. Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.
Latil A; Chêne L; Mangin P; Fournier G; Berthon P; Cussenot O
Prostate; 2003 Sep; 57(1):39-50. PubMed ID: 12886522
[TBL] [Abstract][Full Text] [Related]
19. [Loss of heterozygosity on chromosome 13 in squamous cell carcinomas of the larynx].
Bai S; Zhang X; Wang J
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):35-7. PubMed ID: 10743052
[TBL] [Abstract][Full Text] [Related]
20. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers.
Lu W; Takahashi H; Furusato M; Maekawa S; Nakano M; Meng C; Kikuchi Y; Sudo A; Hano H
Prostate; 2006 Mar; 66(4):405-12. PubMed ID: 16302266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
